Per-Se Technologies forms dedicated e-health division
Clinical software and systems developer Per-Se Technologies has formed a separate division called Per-Se e-Health. Per-Se e-Health will offer private network and Internet-based business-to-business
Clinical software and systems developer Per-Se Technologies has formed a separate division called Per-Se e-Health. Per-Se e-Health will offer private network and Internet-based business-to-business e-health products to physicians throughout the U.S. The Atlanta-based company already provides e-health services to more than 33,000 physicians, with a focus on hospital-affiliated physicians such as radiologists, anesthesiologists, emergency medicine physicians, pathologists, and academic institutions and certain surgical specialties. Per-Se says its national database of processed claims offers unique Web-based decision support that enhances healthcare practices.
© 2000 Miller Freeman, Inc., a United News & Media company.
- Search again
- Homepage
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
